Cargando…

Serotonergic dysregulation is linked to sleep problems in Parkinson's disease

INTRODUCTION: Sleep disturbances are common non-motor symptoms in Parkinson's disease (PD). Experimental studies suggest involvement of the serotonergic system in the regulation of sleep and arousal. Using [(11)C]DASB positron emission tomography, a marker of serotonin transporter availability,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilson, Heather, Giordano, Beniamino, Turkheimer, Federico E., Chaudhuri, Kallol Ray, Politis, Marios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964830/ https://www.ncbi.nlm.nih.gov/pubmed/29845011 http://dx.doi.org/10.1016/j.nicl.2018.03.001

Ejemplares similares

Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson’s disease
por: Niccolini, Flavia, et al.
Publicado: (2019)

Serotonergic Dysfunction in Parkinson's Disease and Its Relevance to Disability
por: Politis, Marios, et al.
Publicado: (2011)

The serotonergic system in Parkinson’s patients with dyskinesia: evidence from imaging studies
por: Pagano, Gennaro, et al.
Publicado: (2017)

Chronic exposure to dopamine agonists affects the integrity of striatal D(2) receptors in Parkinson's patients
por: Politis, Marios, et al.
Publicado: (2017)

Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
por: Wilson, Heather, et al.
Publicado: (2019)

Correction to: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
por: Wilson, Heather, et al.
Publicado: (2022)

Investigation of serotonergic Parkinson's disease-related covariance pattern using [(11)C]-DASB/PET
por: Fu, Jessie Fanglu, et al.
Publicado: (2018)

Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far
por: Boura, Iro, et al.
Publicado: (2022)

Neuroimaging of Sleep Disturbances in Movement Disorders
por: Yousaf, Tayyabah, et al.
Publicado: (2018)

Treatment paradigms in Parkinson's Disease and Covid-19
por: Boura, Iro, et al.
Publicado: (2022)

Potential of animal models for advancing the understanding and treatment of pain in Parkinson’s disease
por: Buhidma, Yazead, et al.
Publicado: (2020)

Infant sleep problems and childhood overweight: Effects of three definitions of sleep problems
por: Alamian, Arsham, et al.
Publicado: (2016)

Parkinson's disease and Covid-19: Is there an impact of ethnicity and the need for palliative care
por: Rukavina, Katarina, et al.
Publicado: (2022)

Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
por: Buddhala, Chandana, et al.
Publicado: (2015)

[(18)F]Florbetapir PET/MR imaging to assess demyelination in multiple sclerosis
por: Carotenuto, Antonio, et al.
Publicado: (2019)

Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s disease
por: Schulz, Jonathan, et al.
Publicado: (2018)

Neuropathological studies of serotonergic and noradrenergic systems in Lewy body disease patients with delusion or depression
por: Mizutani, Masashi, et al.
Publicado: (2022)

Sleep Problems in Parkinson's Disease
por: Hirata, Koichi, et al.
Publicado: (2015)

Clinical application of stem cell therapy in Parkinson's disease
por: Politis, Marios, et al.
Publicado: (2012)

Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease
por: Politis, Marios
Publicado: (2011)

Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next?
por: Politis, Marios
Publicado: (2010)

Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism
por: Leta, Valentina, et al.
Publicado: (2022)

The Dashboard Vitals of Parkinson’s: Not to Be Missed Yet an Unmet Need
por: Chaudhuri, Kallol Ray, et al.
Publicado: (2022)

The range and nature of non-motor symptoms in drug-naive Parkinson’s disease patients: a state-of-the-art systematic review
por: Zis, Panagiotis, et al.
Publicado: (2015)

Early life environmental and pharmacological stressors result in persistent dysregulations of the serotonergic system
por: Wong, Peiyan, et al.
Publicado: (2015)

Slitrk2 deficiency causes hyperactivity with altered vestibular function and serotonergic dysregulation
por: Katayama, Kei-ichi, et al.
Publicado: (2022)

Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An (123)I-FP-CIT SPECT study
por: van der Zande, J.J., et al.
Publicado: (2019)

PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Pagano, Gennaro, et al.
Publicado: (2017)

Linking brain activity during sequential gambling to impulse control in Parkinson's disease
por: Haagensen, Brian N., et al.
Publicado: (2020)

Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease
por: Lawn, Timothy, et al.
Publicado: (2021)

Brain-Heart Link in Schizophrenia: Cognitive Inhibitory Control Deficit in Patients Is Specifically Related to Parasympathetic Dysregulation
por: Lazaridi, Marina, et al.
Publicado: (2022)

Parkinson's Impulse‐Control Scale for the Severity Rating of Impulse‐Control Behaviors in Parkinson's Disease: A Semistructured Clinical Assessment Tool
por: Okai, David, et al.
Publicado: (2016)

Increased insula-putamen connectivity in X-linked dystonia-parkinsonism()
por: Blood, Anne J., et al.
Publicado: (2017)

Commentary: Clinical Correlates of Raphe Serotonergic Dysfunction in Early Parkinson’s Disease
por: Liguori, Claudio, et al.
Publicado: (2015)

Maximized complexity in miniaturized brains: morphology and distribution of octopaminergic, dopaminergic and serotonergic neurons in the parasitic wasp, Trichogramma evanescens
por: van der Woude, Emma, et al.
Publicado: (2017)

Magnetic Resonance Parkinsonism Index Is Associated with REM Sleep Behavior Disorder in Parkinson’s Disease
por: Urso, Daniele, et al.
Publicado: (2022)

Subregional analysis of striatum iron in Parkinson’s disease and rapid eye movement sleep behaviour disorder
por: Alushaj, Erind, et al.
Publicado: (2023)

Role of Prefrontal Serotonergic and Dopaminergic Systems in Encounter-Induced Hyperactivity in Methamphetamine-Sensitized Mice
por: Tanaka, Tatsunori, et al.
Publicado: (2016)

Oxytocinergic Modulation of Stress-Associated Amygdala-Hippocampus Pathways in Humans Is Mediated by Serotonergic Mechanisms
por: Lan, Chunmei, et al.
Publicado: (2022)

A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism
por: Niccolini, Flavia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t79igmsajp97n2chclpqbvnvts